The University of Barcelona (UB) was founded in 1450. Today it boasts of a student body of 91.138 and a research staff of 4.995 members. Degrees are offered in 72 different areas of teaching with numerous postgraduate and doctorate programs as well as continuing education courses. The UB is the largest of the six universities of Barcelona and of the ten in Catalonia; is ranked the first Spanish university, and the twenty third European institutions, in scientific quality and productivity. The UB manages in average 150 European projects per year, for an amount of about 8,6 million euro a year. It is also member of the League of European Research Universities (LERU), as an association of leading research-intensive universities that share the values of high-quality teaching within an environment of internationally competitive research.
The group of Epigenomics of Hematological Neoplasms led by Dr. Martín-Subero is a newly created group aimed at characterizing DNA methylation and histone modification patterns at the genome-wide level in a wide variety of lymphoid neoplasms. The goals of the group are on the one hand, to use epigenomic information to obtain new insights into the cellular and molecular origin of lymphoid leukemias and lymphomas and on the other hand, to identify epigenetic biomarkers with biological and clinical impact in these diseases. This group will participate in the Epigenomics Working group and they will be in charge of the characterization of CLL epigenome in collaboration with the National Genome Analysis Centre.